Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Investments (2016 - 2018)

Historic Long-Term Investments for Organogenesis Holdings (ORGO) over the last 3 years, with Q3 2018 value amounting to $316.3 million.

  • Organogenesis Holdings' Long-Term Investments rose 148.44% to $316.3 million in Q3 2018 from the same period last year, while for Sep 2018 it was $316.3 million, marking a year-over-year increase of 148.44%. This contributed to the annual value of $312.5 million for FY2017, which is 80.58% up from last year.
  • As of Q3 2018, Organogenesis Holdings' Long-Term Investments stood at $316.3 million, which was up 148.44% from $314.8 million recorded in Q2 2018.
  • Organogenesis Holdings' 5-year Long-Term Investments high stood at $316.3 million for Q3 2018, and its period low was $310.0 million during Q4 2016.
  • In the last 3 years, Organogenesis Holdings' Long-Term Investments had a median value of $312.1 million in 2017 and averaged $312.4 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Long-Term Investments skyrocketed by 80.58% in 2017, and later skyrocketed by 148.44% in 2018.
  • Organogenesis Holdings' Long-Term Investments (Quarter) stood at $310.0 million in 2016, then rose by 0.81% to $312.5 million in 2017, then increased by 1.21% to $316.3 million in 2018.
  • Its Long-Term Investments was $316.3 million in Q3 2018, compared to $314.8 million in Q2 2018 and $313.2 million in Q1 2018.